Pharmacists Play a Critical Role in Preventing Antimicrobial Resistance
Pharmacy Times
DECEMBER 3, 2024
Promoting antimicrobial stewardship and providing patient education are examples of strategies to prevent antimicrobial resistance.
Sat.Nov 30, 2024 - Fri.Dec 06, 2024
107 
A Look Back at the Affordable Care Act
Drug Topics
DECEMBER 5, 2024
The Affordable Care Act was passed in 2010 to make health care and prescription medicine more accessible. Did it succeed?
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
UnitedHealthcare CEO Brian Thompson fatally shot in Manhattan: reports
Fierce Healthcare
DECEMBER 4, 2024
UnitedHealth Group abruptly ended its investor day event on Wednesday morning as new reports surfaced that the CEO of its health plan division had been fatally shot. | UnitedHealth Group abruptly ended its investor day event on Wednesday morning as news reports surfaced that the CEO of its health plan division had been fatally shot.
RFK Jr. could 'cost lives in this country' if he pursues changes to US vaccine policy, Gottlieb says
Fierce Pharma
DECEMBER 2, 2024
Robert F. Kennedy Jr.’s appointment last month to lead the U.S. Department of Health and Human Services immediately sent waves of speculation swirling throughout the biopharma industry. | The former FDA Commissioner pointed to the threat of measles if vaccination rates were to decline by 5%.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Patients With Post-COVID POTS Experience Disruptions in Circadian Blood Pressure Rhythm Regulation
Pharmacy Times
DECEMBER 3, 2024
Postural orthostatic tachycardia syndrome (POTS) diagnoses have greatly increased following the COVID-19 pandemic.
Phase 3 Trial to Evaluate Molnupiravir for Treatment of COVID-19 in High-Risk Adults
Drug Topics
DECEMBER 5, 2024
The MOVe-NOW study will assess the investigational oral antiviral using a different formulation than what is currently approved under an emergency use authorization.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Genmab expands its pipeline with $630m Scancell deal
pharmaphorum
DECEMBER 4, 2024
Genmab has licensed another anti-glycan antibody for cancer from UK biotech Scancell as it continues to expand its in-house pipeline.
Combining Ruxolitinib and Supportive Anemia Care Enhances Myelofibrosis Treatment
Pharmacy Times
DECEMBER 5, 2024
The data support the use of supportive anemia care agents in combination with ruxolitinib (Jakafi; Incyte Corp).
Younger, Middle-Aged Adults Face Higher Burden of Neurologic Long COVID Symptoms
Drug Topics
DECEMBER 3, 2024
The higher burden of neurological symptoms among younger and middle-aged adults translated to worse subjective quality of life, according to a recent study.
Healthcare industry needs to get a grip on AI governance in 2025, ECRI warns
Fierce Healthcare
DECEMBER 4, 2024
Risks with AI-enabled health technologies topped the list of the ECRI Institute's annual ranking of health technology hazards. | A well-known safety group debuted its annual report that lays out the top 10 health technology risks for the upcoming year. The risks of AI perpetuating bias or hallucinating answers to medical questions tops the list of risks for 2025.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT+: U.K. to restrict Eli Lilly’s obesity drug to patients with greatest needÂ
STAT
DECEMBER 4, 2024
LONDON — The U.K. will start offering Eli Lilly’s weight loss drug next year, but will restrict the medicine to people with the greatest need as the country tries to adapt to new ways of treating obesity amid surging demand. Health authorities in the U.K. recommend tirzepatide, sold there as Mounjaro, for people with a body mass index of more than 35 and at least one related health condition.
High-Dose Vitamin C Improves Outcomes for Late-Stage Pancreatic Cancer
Pharmacy Times
DECEMBER 3, 2024
High-dose vitamin C, when combined with chemotherapy, has shown the potential to double the survival rate of patients with late-stage metastatic pancreatic cancer.
Cannabis Could Help Reduce Opioid Use in Patients with Chronic Pain
Drug Topics
DECEMBER 2, 2024
Most patients with reduced opioid prescriptions during cannabis use had chronic musculoskeletal pain.
M&A or affiliation improved rural hospitals' margins, reduced risk of closure: report
Fierce Healthcare
DECEMBER 2, 2024
Nearly half of rural hospitals moved out of the high-risk category after a merger, acquisition or affiliation with a larger system, a new analysis has found. | The analysis, conducted by healthcare consulting firm Dobson DaVanzo, found that among 110 rural hospitals that closed between 2011 and 2021, more than half were standalone hospitals without support from larger systems.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
‘Leptin’s last chance’: Mouse study says infamous weight loss drug failure could boost GLP-1s
STAT
DECEMBER 4, 2024
The hormone leptin was discovered 30 years ago to much fanfare. Scientists hoped that leptin, which regulates body fat, could pave the way for obesity treatments. The results in mice were hailed as “miraculous,” and Amgen licensed the hormone for $20 million from Rockefeller University. But its initial promise failed to pan out, as treatments mimicking leptin in the body didn’t spur weight loss.
ASH 2024: Bispecific Antibodies Face Key Challenges for Implementation in Community Cancer Centers
Pharmacy Times
DECEMBER 6, 2024
Donald Moore discusses some of the obstacles that bispecific antibodies have faced in community cancer centers, including misconceptions coupled with a prevalent toxicity profile.
It’s Time to Staunch Our Self-Inflicted Wounds
Drug Topics
DECEMBER 6, 2024
Outside forces are at play, but pharmacists must turn inward to address some challenges in their profession.
Primary care market will see major shifts by 2030 as payers, nontraditional providers gain ground
Fierce Healthcare
DECEMBER 5, 2024
Two years ago, Bain and Company forecasted ma | Nontraditional providers will account for about one-third of the primary care market in 2030, according to Bain and Company. Payer-owned primary care, population-focused models and advanced primary care providers are all poised for growth.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Deadline looms for post-Brexit label changes for UK meds
pharmaphorum
DECEMBER 3, 2024
The MHRA has reminded pharma companies that from 1st January all medicines sold in the UK will have to comply with new labelling requirements
Familiarize Yourself With Updated Clinical Guidelines Recommendations for Restless Legs Syndrome
Pharmacy Times
DECEMBER 1, 2024
Treatment for RLS includes lifestyle modifications, medication, and in some cases, non-drug therapies, aiming to reduce symptoms and improve sleep and daytime functioning.
Q&A: The Future of Biosimilar Pricing at the Pharmacy Counter
Drug Topics
NOVEMBER 30, 2024
Steve Callahan, Senior Director of Advisory & Insights at MMIT, discussed out-of-pocket costs and the impact biosimilars are predicted to have for patients in the future.
Bristol Myers Squibb latest drug company to sue HHS over 340B rebate model
Fierce Healthcare
DECEMBER 3, 2024
Bristol Myers Squibb became the latest large drugmaker to sue the federal government over a plan to change how it doles out drug discounts to hospitals. | Bristol Myers Squibb became the latest large drugmaker to sue the federal government over a plan to change how it doles out drug discounts to hospitals.
STAT+: European regulators approve $16.5 billion deal for Novo Holdings to buy Catalent
STAT
DECEMBER 6, 2024
The European Commission on Friday unconditionally approved a controversial deal in which Novo Holdings, the parent company of Novo Nordisk, one of the largest pharmaceutical companies, would pay $16.5 billion for Catalent, a leading contract drug manufacturer. By taking this step, the executive arm of the European Union removed a significant obstacle to a deal that has generated debate over the extent to which competition in the pharmaceutical industry may be hindered.
Researchers Assess Shingles Vaccination Trends Among Older Adults With COPD
Pharmacy Times
DECEMBER 5, 2024
During a 15-year period, 1 in 5 older adults living with COPD received a shingles vaccine.
Influenza Vaccine Least Effective for Children Facing Secondary Infection
Drug Topics
DECEMBER 2, 2024
Researchers addressed vaccine effectiveness for individuals with direct household contacts that reported influenza.
Amazon taps Hinge Health as MSK care partner, expanding digital health benefits program
Fierce Healthcare
DECEMBER 5, 2024
Amazon has added digital musculoskeletal care company Hinge Health to its health conditions program, a service it rolled out in January to help connect customers with virtual care benefits. | Amazon has added digital musculoskeletal care company Hinge Health to its health conditions program, a service it rolled out in January to help connect customers with virtual care benefits.
Conservative-led Supreme Court appears wary of weighing in on trans care bans
STAT
DECEMBER 4, 2024
Conservative Supreme Court justices appeared skeptical Wednesday of arguments that they should intervene in Tennessee’s ban on gender-affirming care for minors. The court heard arguments in U.S. v. Skrmetti that the state’s ban discriminated against transgender minors and denied them constitutionally equal protections. Outside the courthouse, in a sonic representation of the cultural divisiveness around the issue, advocates for gender-affirming care access blasted Bad Bunny a
FDA Grants Orphan Drug Designation to Novel Gene Therapy for Fabry Disease
Pharmacy Times
DECEMBER 5, 2024
Fabry disease is a rare lysosomal disorder that causes excessive deposition of lipids in tissues.
Postpartum Depression Rates Increase With Higher BMI
Drug Topics
DECEMBER 3, 2024
Women with prepregnancy overweight or obesity may be more likely to experience postpartum depression.
How automating flow cytometry is revolutionising cancer diagnosis and treatment
pharmaphorum
DECEMBER 4, 2024
Discover how the automation of flow cytometry is transforming cancer diagnosis and treatment for breast, prostate, endometrial, pancreatic, kidney, and melanoma cancers. Explore the latest advancements in the field.
STAT+: U.S. Patent Office pulls controversial rule to curb pharma patent abuse
STAT
DECEMBER 4, 2024
In an unexpected move, the U.S. Patent & Trademark Office has withdrawn a controversial proposal that was designed to prevent pharmaceutical companies from abusing the patent system. Specifically, the proposed rule was crafted to stem the use of so-called patent thickets , which are wielded by drug companies to delay the arrival of lower-cost generic medicines in the marketplace.
Analysis Finds Low-Income Countries Face More Cancer-Related Deaths and Inequities in Therapy Access
Pharmacy Times
NOVEMBER 30, 2024
Potential solutions can include international funding, improved primary health care measures, and cost-effective screening methods.
CMS names two drug manufacturers for cell and gene therapy model
Fierce Healthcare
DECEMBER 4, 2024
The Centers for Medicare & Medicaid Services has successfully negotiated agreements with two drug manufacturers to participate in the newly created Cell and Gene Therapy Access Model. | The two drugs treat sickle cell disease, the stated first priority of the new CMS model set to begin in January.
Let's personalize your content